Exact Mass: 391.1024856000001
Exact Mass Matches: 391.1024856000001
Found 166 metabolites which its exact mass value is equals to given mass value 391.1024856000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glycoperine
Glycoperine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound and an oxacycle. Glycoperine is a natural product found in Haplophyllum acutifolium and Haplophyllum latifolium with data available.
Glucoconringiin
Isolated from Conringia orientalis (hares ear mustard). Glucoconringiin is found in horseradish, fats and oils, and horseradish tree. Glucoconringiin is found in fats and oils. Glucoconringiin is isolated from Conringia orientalis (hares ear mustard).
8-Methylaminoriboflavin
C17H21N5O6 (391.14917660000003)
Chlorohaloperidol
N-4-Carboxybenzylglucamine dithiocarbamate
Zidebactam
C13H21N5O7S (391.11616360000005)
5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside
5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside is soluble (in water) and a very weakly acidic compound (based on its pKa). 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside can be found in corn, which makes 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside a potential biomarker for the consumption of this food product.
[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-
1-(2-hydroxy-3-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|11-Acetonyl-O-desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
O-[alpha-L-Arabinopyranosyl(1?6)-beta-D-glucopyranoside-2-Hydroxy-3-methyl-2-butenenitrile
6-Acetonyl-N-methyl-dihydrodecarine
C23H21NO5 (391.14196560000005)
2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3<4H>-one)-beta-D-glucopyranoside|2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3[4H]-one)-beta-D-glucopyranoside
1-(3-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|Acetonyl-11-O-Desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
1-(1-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|O-Demethyldihydrochelerythrinyl-11-aceton
C23H21NO5 (391.14196560000005)
(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid
Glycoperine
Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids
PharmaGSID_47330
C21H15F2N5O (391.12446040000003)
CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8922; ORIGINAL_PRECURSOR_SCAN_NO 8921 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8944; ORIGINAL_PRECURSOR_SCAN_NO 8942 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8967; ORIGINAL_PRECURSOR_SCAN_NO 8965 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8982; ORIGINAL_PRECURSOR_SCAN_NO 8980 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8963; ORIGINAL_PRECURSOR_SCAN_NO 8961 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8988; ORIGINAL_PRECURSOR_SCAN_NO 8987
Asp Gly Asn Ser
Asp Gly Ser Asn
Asp Asn Gly Ser
Asp Asn Ser Gly
Asp Ser Gly Asn
Asp Ser Asn Gly
Gly Asp Asn Ser
Gly Asp Ser Asn
Gly Asn Asp Ser
Gly Asn Ser Asp
Gly Ser Asp Asn
Gly Ser Asn Asp
Asn Asp Gly Ser
Asn Asp Ser Gly
Asn Gly Asp Ser
Asn Gly Ser Asp
Asn Ser Asp Gly
Asn Ser Gly Asp
Ser Asp Gly Asn
Ser Asp Asn Gly
Ser Gly Asp Asn
Ser Gly Asn Asp
Ser Asn Asp Gly
Ser Asn Gly Asp
Lys-His-OH
C17H21N5O6 (391.14917660000003)
JWH 398 N-(5-hydroxypentyl) metabolite
C24H22ClNO2 (391.13389820000003)
3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile
Tetrabutylammonium dichlorobromate
C16H36BrCl2N (391.14080160000003)
Fluoroclebopride
Fluoroclebopride binds reversibly to dopamine receptors. 18F labeled fluoroclebopride has been used as a probe for studying D2/D3 receptor availability via PET in various monkey models[1][2].
Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE
(E)-4-[3,4-bis(4-chlorophenyl)butan-2-ylamino]-4-oxobut-2-enoic acid
GRI 977143
C22H17NO4S (391.08782420000006)
1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine
C12H20F3N3O6S (391.1024856000001)
2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-
C20H22ClNO5 (391.11864320000007)
Fmoc-(R)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
3-((BENZYLOXY)METHYL)-4-ISOPROPYL-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-5(4H)-ONE
C20H20F3N3O2 (391.15075360000003)
(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE
Tonabersat
C20H19ClFNO4 (391.0986576000001)
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE
C18H21N3O5S (391.12018560000007)
Fmoc-(S)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
Zidebactam
C13H21N5O7S (391.11616360000005)
C254 - Anti-Infective Agent > C258 - Antibiotic
7-((2-amino-2-(1-formylcyclopropyl)ethyl)amino)-6-fluoro-1-(2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
C19H19F2N3O4 (391.13435580000004)
tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate
C18H21N3O5S (391.12018560000007)
(1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester
(5-acetamido-3,4-diacetyloxy-6-ethylsulfanyloxan-2-yl)methyl acetate
(2,3,4,5,6-pentafluorophenyl) 1-(thiophen-2-ylmethyl)piperidine-4-carboxylate
Methyl-2-bromo-3-{4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl} propionate
C19H22BrNO3 (391.07829620000007)
Tavapadon
C19H16F3N3O3 (391.11437020000005)
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].
n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide
C19H21NO6S (391.10895260000007)
Chloroquine Hydrochloride
C18H28Cl3N3 (391.13486980000005)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate
3-Cyclohexyl-10-methyl-2-thiophen-2-ylpyrimido[4,5-b]quinoline-4,5-dione
C22H21N3O2S (391.13544060000004)
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-[[1-(3-methylphenyl)-2-imidazolyl]thio]acetamide
Unii-gmy695BP6Q
C21H15F2N5O (391.12446040000003)
TPA-023B is a high-affinity and orally active GABAA receptor α2/α3 subtype (Kis of 0.73 nM/2 nM) partial agonist and a α1 subtype (Ki of 1.8 nM) antagonist. TPA-023B has non-sedating anxiolytic-like properties[1].
Dimetotiazine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside
2-(glutathion-S-yl)-2-carboxypropane
C14H21N3O8S-2 (391.10493060000005)
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-5-hydroxy-N-sulfooxypentanimidothioate
(1R,2S,3S,4S,5R,6S,8R,9R,12R)-5,6-dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate
(1S,2S,3S,4S,5S,8R,9R,12S)-5,12-dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate
[(3S)-3-acetamido-4-[[(2S)-1-[[(1S)-1-carboxy-3-methylbutyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutyl]-oxido-oxophosphanium
5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside
Dithiazaninum
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D004396 - Coloring Agents > D005456 - Fluorescent Dyes
3,3-Diethylthiadicarbocyanine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D004396 - Coloring Agents > D005456 - Fluorescent Dyes
4-[3-(4-Methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
C22H21N3O2S (391.13544060000004)
4-[3-(3-Methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
C22H21N3O2S (391.13544060000004)
1-S-[3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose
4-Chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester
C20H14ClN5O2 (391.08359740000003)
2-[[2-(4-chlorophenoxy)-1-oxoethyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide
C18H18ClN3O5 (391.09349280000004)
2-[2-[2-(4-Chlorophenyl)-2-oxoethoxy]phenyl]isoindole-1,3-dione
C22H14ClNO4 (391.0611314000001)
2-Hydroxybenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
C23H21NO5 (391.14196560000005)
4-[5-(4-morpholinylsulfonyl)-2-thiophenyl]-3-phenyl-2H-furan-5-one
N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide
C21H17N3O3S (391.09905720000006)
N-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide
C16H17N5O5S (391.09503520000004)
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide
C16H17N5O3S2 (391.07727719999997)
2-[(4Z)-2,5-dioxo-4-[[1-(4-phosphonophenyl)pyrrol-2-yl]methylidene]imidazolidin-1-yl]acetic acid
(4E)-4-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-2,3-dihydro-1H-acridine-9-carboxylic acid
C23H21NO5 (391.14196560000005)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol
8-Methylamino-riboflavin
C17H21N5O6 (391.14917660000003)
Glucoconringiin
A hydroxy-alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl group at the anomeric sulfur.
AZ 12216052
C19H22BrNOS (391.06053820000005)
AZ 12216052 is a mGluR8 positive allosteric modulator, and helps mGluR8 modulate signaling inputing to retinal ganglion cells. AZ 12216052 exhibits antianxiety effect[1][2][3][4].
CAY10698
CAY10698 (compound 1) is a potent and selective inhibitor of 12-Lipoxygenase (12-LOX) with an IC50 of 5.1 μM. CAY10698 is inactive against 5-LOX, 15-LOX-1, 15-LOX-2 and COX-1/2[1].
CTEP
C19H13ClF3N3O (391.06991940000006)
CTEP (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors. CTEP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.